Literature DB >> 25332623

Copper deficiency with 20q deletion and a paroxysmal nocturnal haemoglobinuria clone presenting with bicytopenia.

Rekha Bhat1, Swati Pai1, Ashish Dixit2.   

Abstract

Copper plays an essential role in numerous enzymatic reactions in the human body and hypocupremia manifests itself as cytopenias and/or neuropathy. Copper deficiency is also a mimic of dysplasia, and this may cause diagnostic difficulties with true myelodysplasia. In this case report, we present a patient with anaemia, thrombocytopenia and marginally decreased leucocyte count, who was found to have low copper levels. In addition, he had isolated 20q deletion and a small paroxysmal nocturnal haemoglobinuria clone, which have not been reported previously. His counts normalized after steroid therapy followed by copper supplementation. This case is presented to highlight the fact that copper deficiency may be present without the characteristic morphologic changes, and may be coexisting with other abnormalities.

Entities:  

Keywords:  20q deletion; Copper deficiency; Isolated 20qdel; PNH; Paroxysmal nocturnal haemoglobinuria

Year:  2014        PMID: 25332623      PMCID: PMC4192260          DOI: 10.1007/s12288-014-0419-8

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  18 in total

Review 1.  Iron and copper metabolism.

Authors:  Miguel Arredondo; Marco T Núñez
Journal:  Mol Aspects Med       Date:  2005 Aug-Oct

2.  Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura.

Authors:  Chad P Soupir; Jo-Anne Vergilio; Eileen Kelly; Paola Dal Cin; David Kuter; Robert P Hasserjian
Journal:  Br J Haematol       Date:  2008-11-26       Impact factor: 6.998

3.  Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients.

Authors:  P J Kurtin; G W Dewald; D J Shields; C A Hanson
Journal:  Am J Clin Pathol       Date:  1996-11       Impact factor: 2.493

Review 4.  Metabolic crossroads of iron and copper.

Authors:  James F Collins; Joseph R Prohaska; Mitchell D Knutson
Journal:  Nutr Rev       Date:  2010-03       Impact factor: 7.110

5.  Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.

Authors:  Thorsten Braun; Stéphane de Botton; Anne-Laure Taksin; Sophie Park; Odile Beyne-Rauzy; Valérie Coiteux; Rosa Sapena; Anne Lazareth; Geneviève Leroux; Khaled Guenda; Bruno Cassinat; Michaela Fontenay; Norbert Vey; Agnès Guerci; François Dreyfus; Dominique Bordessoule; Aspasia Stamatoullas; Sylvie Castaigne; Christine Terré; Virginie Eclache; Pierre Fenaux; Lionel Adès
Journal:  Leuk Res       Date:  2011-03-10       Impact factor: 3.156

Review 6.  Hypocupremia associated cytopenia and myelopathy: a national retrospective review.

Authors:  Alemayehu A Gabreyes; Hina Naz Abbasi; Kirsten P Forbes; Grant McQuaker; Andrew Duncan; Ian Morrison
Journal:  Eur J Haematol       Date:  2012-11-22       Impact factor: 2.997

7.  Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse.

Authors:  C D Vulpe; Y M Kuo; T L Murphy; L Cowley; C Askwith; N Libina; J Gitschier; G J Anderson
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

8.  Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome.

Authors:  Thomas Fong; Ravi Vij; Anitha Vijayan; John DiPersio; Morey Blinder
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

9.  New aspects of copper and iron metabolism in the myelodysplastic syndromes.

Authors:  Judit Várkonyi; Terézia Szabó; Piroska Sebestyén; Attila Tordai; Hajnalka Andrikovics; Géza Kollai; István Karádi
Journal:  Chemotherapy       Date:  2006-02-03       Impact factor: 2.544

10.  Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome.

Authors:  Hongbo Wang; Tatsuya Chuhjo; Shizuka Yasue; Mitsuhiro Omine; Shinji Nakao
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.